Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Engert

Showing results (171-180 of 379) with videos related to

Pageof 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2019
Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage Hodgkin LymphomaCarsten Kobe, Helen Goergen, Michael Fuchs, et al.
International Journal of Cancer|March 3, 2007
The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV-negative cases of classical Hodgkin's lymphomaChristoph Renné, Nora Hinsch, Klaus Willenbrock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study groupAndreas Josting, Jeremy Franklin, Michael May, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Depletion of cellular cholesterol and lipid rafts increases shedding of CD30Bastian von Tresckow, Karl-Josef Kallen, Elke Pogge von Strandmann, et al.
Haematologica|December 3, 2009
Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic reviewChristine Herbst, Fareed A Rehan, Corinne Brillant, et al.
Radiation Oncology (London, England)|July 5, 2018
Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPYChristian Baues, Simone Marnitz, Andreas Engert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 TrialsHeinz Haverkamp, Boris Böll, Dennis A Eichenauer, et al.
Leukemia & Lymphoma|November 21, 2008
Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphomaRoger Rautert, Timo Schinköthe, Jeremy Franklin, et al.
Leukemia & Lymphoma|January 21, 2003
Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapyAnke S Krause, Martin R Weihrauch, Udo Bode, et al.
Leukemia & Lymphoma|December 4, 2018
Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study GroupStefanie Kreissl, Helen Goergen, Horst Müller, et al.
Pageof 38

Showing results (171-180 of 379) with videos related to

Sort By:
Pageof 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2019
Predictive Value of Positron Emission Tomography/Computed Tomography After ABVD-Based Chemotherapy in Early-Stage Hodgkin LymphomaCarsten Kobe, Helen Goergen, Michael Fuchs, et al.
International Journal of Cancer|March 3, 2007
The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV-negative cases of classical Hodgkin's lymphomaChristoph Renné, Nora Hinsch, Klaus Willenbrock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study groupAndreas Josting, Jeremy Franklin, Michael May, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Depletion of cellular cholesterol and lipid rafts increases shedding of CD30Bastian von Tresckow, Karl-Josef Kallen, Elke Pogge von Strandmann, et al.
Haematologica|December 3, 2009
Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic reviewChristine Herbst, Fareed A Rehan, Corinne Brillant, et al.
Radiation Oncology (London, England)|July 5, 2018
Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPYChristian Baues, Simone Marnitz, Andreas Engert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2015
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 TrialsHeinz Haverkamp, Boris Böll, Dennis A Eichenauer, et al.
Leukemia & Lymphoma|November 21, 2008
Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphomaRoger Rautert, Timo Schinköthe, Jeremy Franklin, et al.
Leukemia & Lymphoma|January 21, 2003
Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapyAnke S Krause, Martin R Weihrauch, Udo Bode, et al.
Leukemia & Lymphoma|December 4, 2018
Survivors' perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study GroupStefanie Kreissl, Helen Goergen, Horst Müller, et al.
Pageof 38